MedTrace Logo

Use of Minocicline in Patients With Stroke

NCT01556802 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 134

Last updated 2012-03-16

No results posted yet for this study

Summary

The investigators will evaluate the National Institute of Health Stroke Scale/Score (NIHSS)in patients with stroke, and then give Minocycline 100mg po every 12 hours or placebo for five days, then perform periodic evaluations to determine the status and degree of neurological sequelae developed.

Conditions

  • Stroke
  • Brain Ischemia
  • Paralysis

Interventions

DRUG

Minocicline

Minocicline 100mg oral twice a day for 5 days

DRUG

Placebo

Pills with vegetable fibers one pill oral twice a day for five days

Sponsors & Collaborators

  • Hospital Universitario Hernando Moncaleano Perdomo

    lead OTHER

Principal Investigators

  • Nataly Bedoya, Internist · Universidad Surcolombiana

  • Hernan Vargas, Internist · Universidad Surcolombiana

  • Hugo Osorio, Internist · Universidad Surcolombiana

  • Guillermo Gonzalez, Neurologist · Universidad Surcolombiana

  • Javier Saldaña, Epidemiology · Universidad Surcolombiana

  • Efrain Amaya, Neurologist · Hospital Hernando Moncaleano Perdomo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2011-11-30
Completion
2013-01-31

Countries

  • Colombia

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01556802 on ClinicalTrials.gov